Tag: Health spending
- R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia
- Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million
- Nouscom to present re‑treatment data in Lynch Syndrome at ESMO 2026
- ViiV Healthcare to unveil new HIV treatment data at AIDS 2026
- Jasper Therapeutics merges with Kira Pharmaceuticals
